Overexpression of RhoA enhances peritoneal dissemination : RhoA suppression with Lovastatin may be useful for ovarian cancer

• HORIUCHI Akiko

  Department of Obstetrics and Gynecology, Shinshu University School of Medicine

• KIKUCHI Norihiko

  Department of Obstetrics and Gynecology, Shinshu University School of Medicine

• OSADA Ryosuke

  Department of Obstetrics and Gynecology, Shinshu University School of Medicine

• WANG Cuiju

  Department of Obstetrics and Gynecology, Shinshu University School of Medicine

• HAYASHI Akiko

  Department of Obstetrics and Gynecology, Shinshu University School of Medicine

• NIKAIDO Toshio

  Department of Regenerative Medicine, Toyama University, Faculty of Medicine

• KONISHI Ikuo

  Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine

Abstract

The definitive version is available at www.blackwell-synergy.comArticleCANCER SCIENCE. 99(12):2532-2539 (2008)

Journal

• CANCER SCIENCE

  CANCER SCIENCE 99 (12), 2532-2539, 2008-12-10

  BLACKWELL PUBLISHING

Details

• CRID: 1571135650692651776
• NII Article ID: 10024014761
• NII Book ID: AA11808050
• ISSN: 13479032
• Web Site: http://hdl.handle.net/10091/3211
• Web Site: https://soar-ir.repo.nii.ac.jp/records/3927
• Web Site: https://search.jamas.or.jp/link/ui/2009186499
• Text Lang: en
• Data Source:
  • CiNii Articles